Transrectal ultrasound guided biopsy (TRUS biopsy) can lead to inaccurate Gleeson scores, under scoring Gleeson values, in 3040% of prostate cancer cases. Multiparametric MRI guided biopsy advantages over transrectal ultrasound guided biopsy (TRUS Biopsy) include:
Lower risk of pain and infection.
Find more clinically significant cancers.
Find fewer clinically insignificant cancers.
Reduce the total number of biopsies required.